CHRS vs CHTR · rev $26.6M vs P/E 11, rev $13.53B
Coherus BioSciences Inc (CHRS) versus Charter Communications Inc (CHTR) — a side-by-side from cached financials, not a winner call.
Coherus BioSciences Inc (CHRS) is a biotechnology company listed on US.
Charter Communications Inc (CHTR) is a telecom services company listed on US.
Latest reported CHRS revenue for 2026-06-30 was $26.6M. Net income was -$59.0M. CHRS currently screens at market cap $223.7M.
Latest reported CHTR revenue for 2026-06-30 was $13.53B. Net income was $1.29B. Revenue was down 0.5% from 2026-03-31 to 2026-06-30. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
CHRS currently screens at market cap $223.7M. CHTR currently screens at market cap $56.24B and trailing P/E 11.5.
Not investment advice. Open the CHRS and CHTR stock pages for the full models.
Not investment advice.